Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01882166|
Recruitment Status : Unknown
Verified July 2014 by St. Olavs Hospital.
Recruitment status was: Recruiting
First Posted : June 20, 2013
Last Update Posted : July 22, 2014
|Condition or disease||Intervention/treatment||Phase|
|Infertility, Female||Drug: fostimon Drug: puregon||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment|
|Study Start Date :||October 2013|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||December 2014|
subcutaneous 150 IE Fostimon®. When leading follicles are > 17 mm ovulation will be induced by Ovitrelle® 500μg sc(hCG-injection). Ovum pick up (OPU) will be performed 32-36 hours later.
Other Name: urinary FSH
subcutaneous 150 IE Puregon®. When leading follicles are > 17 mm ovulation will be induced by Ovitrelle® 500μg sc(hCG-injection). Ovum pick up (OPU) will be performed 32-36 hours later.
Other Name: recombinant FSH
- Embryo quality [ Time Frame: 2 days ]time-lapse recordings for all embryos will be evaluated by use of the EmbryoViewer (software developed for the EmbryoScope)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01882166
|Contact: Peter M Kragh, phd||Peter.Michael.Kragh@stolav.no|
|IVF Unit, St. Olavs Hospital||Recruiting|
|Trondheim, Norway, 7006|
|Study Chair:||Arne Sunde, phd||St. Olavs Hospital|